Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Vector used for displaying antigenic epitope by using hepatitis B virus core particles, animal vaccine, and preparation method thereof

A technology of hepatitis B virus and core particles, applied in botany equipment and methods, biochemical equipment and methods, using vectors to introduce foreign genetic material, etc., can solve the problems of high production cost, high product price and inability to promote protein vaccines, etc. Achieve outstanding immune effect, reduce production cost, and be easy to construct

Inactive Publication Date: 2013-07-03
北京中农创新生物工程研究院有限公司
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Second, protein vaccines are expensive to produce
However, the implementation of this technology requires the use of efficient production methods such as animal bioreactors, otherwise it is likely to be too expensive to promote

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Vector used for displaying antigenic epitope by using hepatitis B virus core particles, animal vaccine, and preparation method thereof
  • Vector used for displaying antigenic epitope by using hepatitis B virus core particles, animal vaccine, and preparation method thereof
  • Vector used for displaying antigenic epitope by using hepatitis B virus core particles, animal vaccine, and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0041]The protective power of a vaccine lies in the strong immune response it induces in the body, and the strength of the body's immune response depends on the strength of the immune signal provided by the antigen. To improve the presentation of antigenic proteins to immune signals (epitopes), several possible technologies are worth exploring. The first technique is to create harmless mutants through genome manipulation, an idea that has been advocated and actually explored by many. However, this technical route also has two potential weaknesses: First, the work is relatively difficult. It is a very difficult task to find out the part where the pathogen can be deleted or mutated, so that the toxicity of the pathogen can be reduced or even disappeared without reducing the value-added ability of the pathogen. Difficult and long-term work; secondly, even if a harmless mutant strain is successfully developed, it is not a matter of once and for all, because after a long-term use o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a vector used for displaying antigenic epitope by using hepatitis B virus core particles, an animal vaccine, and a preparation method thereof. According to the invention, a DNA artificial synthesis method is adopted, and a coding DNA sequence of amino acid necessary for hepatitis B virus core protein is synthesized. In the synthesis process, a coding DNA sequence of hepatitis B virus core protein true peptide 1-149 site amino acid is adopted as a framework; 79-82 site amino acid coding sequence in the framework is removed, and only coding DNA relevant to virus particle assembly is preserved; for facilitating the insertion of other antigenic proteins in the hepatitis B virus core particle protein, a segment of DNA sequence coding flexible peptide is specially inserted at a position of the 79-82 site amino acid, and three endonuclease sites are introduced into the sequence, such that gene operation is facilitated; the above synthesized DNA segment is cloned into a gene cloning vector pUC18, such that a special vector pZNVC used for displaying antigenic epitope is formed; a synthesized DNA segment of an antigenic protein gene or coding epitope is inserted into pZNVC, and fusion protein is expressed in prokaryotic organisms or eukaryotic organisms. 78 amino acids on N-end of hepatitis B virus and 68 amino acids on C-end of hepatitis B virus can be folded into two columnar bodies, such that building blocks used for assembling the core protein particle are formed; flexible peptide forms a bond connecting the two columnar bodies; and proteins inserted between the flexible peptide protrude on the surface of the viral particles. The flexible peptide is composed of a series of small amino acids without side chain, and has certain flexibility. The flexible peptide does not affect the hepatitis B virus core particle protein and antigenic protein in independently and respectively folding into natural molecular structures. pZNVC is used for displaying antigenic protein antigenic epitopes, such that the existence state of the antigenic epitopes on natural pathogen outer membrane can be simulated to a maximal extent.

Description

technical field [0001] The invention relates to the field of genetic engineering DNA vaccines, in particular to a carrier for displaying antigenic epitopes by virus core particles, a vaccine and a preparation method thereof. Background technique [0002] At present, there are three main types of industrially produced vaccines: one is to kill or weaken pathogens and use them as antigens to directly manufacture vaccines; the other is to use genetic engineering technology to clone antigen genes into bacteria and produce antigenic proteins through bacterial fermentation molecules, which are then made into protein vaccines. The third type is to inject the gene encoding the antigenic protein into the body to continuously produce the antigenic protein in the body, which is DNA vaccine. However, in terms of the type of antigen, DNA vaccines are essentially protein vaccines. Among these three types of vaccines, protein vaccines are the safest, because they do not contain the geneti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/63C12N15/51C07K14/02A61K39/29A61P31/20A61P1/16
Inventor 陈永福张国华郑立于娟娟张岩松
Owner 北京中农创新生物工程研究院有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products